| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 1.43e-03 | 530 | 20 | 4 | GO:0062023 | |
| GeneOntologyCellularComponent | extracellular matrix | 3.12e-03 | 656 | 20 | 4 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 3.15e-03 | 658 | 20 | 4 | GO:0030312 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 3.70e-03 | 332 | 20 | 3 | GO:0005788 | |
| HumanPheno | Fifth metacarpal with ulnar notch | 2.16e-06 | 2 | 8 | 2 | HP:0005900 | |
| Domain | EGF_Ca-bd_CS | 3.74e-08 | 97 | 19 | 5 | IPR018097 | |
| Domain | EGF_CA | 4.14e-08 | 99 | 19 | 5 | PS01187 | |
| Domain | ASX_HYDROXYL | 4.36e-08 | 100 | 19 | 5 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 5.84e-08 | 106 | 19 | 5 | IPR000152 | |
| Domain | EGF_CA | 1.18e-07 | 122 | 19 | 5 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.28e-07 | 124 | 19 | 5 | IPR001881 | |
| Domain | EGF | 3.04e-06 | 235 | 19 | 5 | SM00181 | |
| Domain | EGF_3 | 3.04e-06 | 235 | 19 | 5 | PS50026 | |
| Domain | EGF-like_dom | 4.04e-06 | 249 | 19 | 5 | IPR000742 | |
| Domain | EGF_1 | 4.54e-06 | 255 | 19 | 5 | PS00022 | |
| Domain | EGF-like_CS | 5.08e-06 | 261 | 19 | 5 | IPR013032 | |
| Domain | EGF_2 | 5.47e-06 | 265 | 19 | 5 | PS01186 | |
| Domain | TB | 2.05e-05 | 7 | 19 | 2 | PF00683 | |
| Domain | - | 2.74e-05 | 8 | 19 | 2 | 3.90.290.10 | |
| Domain | TB_dom | 3.51e-05 | 9 | 19 | 2 | IPR017878 | |
| Domain | TB | 3.51e-05 | 9 | 19 | 2 | PS51364 | |
| Domain | EGF_CA | 8.66e-05 | 86 | 19 | 3 | PF07645 | |
| Domain | cEGF | 3.14e-04 | 26 | 19 | 2 | PF12662 | |
| Domain | cEGF | 3.14e-04 | 26 | 19 | 2 | IPR026823 | |
| Domain | hEGF | 3.65e-04 | 28 | 19 | 2 | PF12661 | |
| Domain | Growth_fac_rcpt_ | 5.02e-04 | 156 | 19 | 3 | IPR009030 | |
| Domain | LAM_G_DOMAIN | 6.74e-04 | 38 | 19 | 2 | PS50025 | |
| Domain | Laminin_G_2 | 7.47e-04 | 40 | 19 | 2 | PF02210 | |
| Domain | LamG | 9.04e-04 | 44 | 19 | 2 | SM00282 | |
| Domain | Laminin_G | 1.57e-03 | 58 | 19 | 2 | IPR001791 | |
| Domain | - | 4.14e-03 | 95 | 19 | 2 | 2.60.120.200 | |
| Domain | EGF | 7.16e-03 | 126 | 19 | 2 | PF00008 | |
| Domain | ConA-like_dom | 2.05e-02 | 219 | 19 | 2 | IPR013320 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA | 2.19e-05 | 8 | 13 | 2 | M47850 | |
| Pathway | REACTOME_INFLAMMASOMES | 1.63e-04 | 21 | 13 | 2 | M1072 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 3.83e-04 | 32 | 13 | 2 | MM14854 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 5.13e-04 | 37 | 13 | 2 | M27134 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 5.42e-04 | 38 | 13 | 2 | MM14874 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 5.71e-04 | 39 | 13 | 2 | MM14601 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 7.27e-04 | 44 | 13 | 2 | M26969 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 8.29e-04 | 47 | 13 | 2 | M646 | |
| Pathway | REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS | 1.18e-03 | 56 | 13 | 2 | M1074 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 1.30e-03 | 59 | 13 | 2 | M39886 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 2.21e-03 | 77 | 13 | 2 | MM14670 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 3.27e-03 | 94 | 13 | 2 | M1041 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 5.10e-03 | 118 | 13 | 2 | MM15588 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 5.27e-03 | 120 | 13 | 2 | MM14982 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 5.62e-03 | 124 | 13 | 2 | M27285 | |
| Pubmed | LTBP3 Pathogenic Variants Predispose Individuals to Thoracic Aortic Aneurysms and Dissections. | 3.14e-07 | 2 | 20 | 2 | 29625025 | |
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 30306291 | ||
| Pubmed | Genetic analysis of the contribution of LTBP-3 to thoracic aneurysm in Marfan syndrome. | 3.14e-07 | 2 | 20 | 2 | 26494287 | |
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 20301776 | ||
| Pubmed | 6.55e-05 | 21 | 20 | 2 | 20708005 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q21 | 2.68e-03 | 177 | 20 | 2 | chr15q21 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 5.97e-04 | 51 | 13 | 2 | 870 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 7.23e-03 | 181 | 13 | 2 | 694 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.34e-05 | 196 | 20 | 4 | M3008 | |
| Coexpression | NABA_CORE_MATRISOME | 5.03e-05 | 275 | 20 | 4 | M5884 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.03e-08 | 193 | 20 | 5 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.08e-08 | 194 | 20 | 5 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-06 | 189 | 20 | 4 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-06 | 189 | 20 | 4 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 1.42e-06 | 190 | 20 | 4 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.45e-06 | 191 | 20 | 4 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-06 | 192 | 20 | 4 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-06 | 192 | 20 | 4 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-06 | 192 | 20 | 4 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-06 | 192 | 20 | 4 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.54e-06 | 194 | 20 | 4 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.54e-06 | 194 | 20 | 4 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.64e-06 | 197 | 20 | 4 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | PCW_10-12|World / Celltypes from embryonic and fetal-stage human lung | 1.64e-06 | 197 | 20 | 4 | 47fd8b0d596c5db1a722473c8efbb17a6bbe7538 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.74e-06 | 200 | 20 | 4 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.74e-06 | 200 | 20 | 4 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.90e-05 | 135 | 20 | 3 | b128596653a5e3b64ed7f657bbfeda35438e2e48 | |
| ToppCell | facs-Skin-nan-24m-Epithelial-inner_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.38e-05 | 155 | 20 | 3 | fa2776d258e0420b2895de1008e292ad7725dac0 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T7|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.99e-05 | 162 | 20 | 3 | c6ace47daf32495b25793d39b72382978349597d | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_progenitors-Progenitor|lymph-node_spleen / Manually curated celltypes from each tissue | 5.27e-05 | 165 | 20 | 3 | 7b992843bd8ef92a7a76b1d681fa84efde6f5bdd | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.17e-05 | 174 | 20 | 3 | 3c47d069bd836599a8d40eae485c23d4d3487517 | |
| ToppCell | E12.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.50e-05 | 177 | 20 | 3 | 5cdf413f82376a95467322b16d10b0d1e7557e2d | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 6.94e-05 | 181 | 20 | 3 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.94e-05 | 181 | 20 | 3 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | P03|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.41e-05 | 185 | 20 | 3 | a07dbe1f76e40734a28826423a5cc64b8e56af5e | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.53e-05 | 186 | 20 | 3 | 35c88cc4eb388811fcac4323b549e5897fa8dc27 | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.53e-05 | 186 | 20 | 3 | d998c5b00083cf2a7cd5341a98b7374b4de73c63 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.65e-05 | 187 | 20 | 3 | 13731298bc562ec29582f5da1b4c97261284f6f1 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_B-GC_B_(I)|GI_small-bowel / Manually curated celltypes from each tissue | 7.65e-05 | 187 | 20 | 3 | a92cade2a835f5fce8de1e14650af8cdd818c296 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 7.65e-05 | 187 | 20 | 3 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 7.65e-05 | 187 | 20 | 3 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | droplet-Lung-immune-endo-depleted|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-05 | 189 | 20 | 3 | c3fb363bb0156ffb3367c200f548faebda64ab4a | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-05 | 189 | 20 | 3 | 2a2953f6b1b7d070d739dcaf7285fce6e097d9e4 | |
| ToppCell | droplet-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.89e-05 | 189 | 20 | 3 | 5a636e952da9b1fd26aa17f7b129054f2da322b5 | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 8.02e-05 | 190 | 20 | 3 | 1196b8ea2c44c7c80f5ee589dd517e6a413f2077 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 8.02e-05 | 190 | 20 | 3 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.02e-05 | 190 | 20 | 3 | 9cd147a174017ebda23cc47b6d4552d898acd092 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.02e-05 | 190 | 20 | 3 | 841cd55861b43578d704418b9bc0af2e8b88323a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.14e-05 | 191 | 20 | 3 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 8.14e-05 | 191 | 20 | 3 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.14e-05 | 191 | 20 | 3 | a05e9a7eb137d804570dd7d8905975d735738767 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.14e-05 | 191 | 20 | 3 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | hematopoetic_progenitors-CD34+_CLP|World / Lineage and Cell class | 8.14e-05 | 191 | 20 | 3 | 32f2537c97c9984629d61c6f34a337f555146ad4 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.14e-05 | 191 | 20 | 3 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.27e-05 | 192 | 20 | 3 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.27e-05 | 192 | 20 | 3 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | droplet-Lung-1m-Mesenchymal|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.27e-05 | 192 | 20 | 3 | 01433bd4794b8bcc51fe4249124a0f4289b9d6e2 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.27e-05 | 192 | 20 | 3 | de9c1536d5aee86f9c62acbc54ca8fa581c00f17 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.27e-05 | 192 | 20 | 3 | ff4b728a55c2550c806c47e9ae3d057c35df8464 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.27e-05 | 192 | 20 | 3 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.27e-05 | 192 | 20 | 3 | 25492568f9cbe097b7bb1db50d8b817c80ea87d7 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-alveolar_fibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.27e-05 | 192 | 20 | 3 | 2d3790bd80a7f214b37094121a2a86ff16362569 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.40e-05 | 193 | 20 | 3 | 03678162648bd5b1d65a5450b60c8863edbf95c7 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.40e-05 | 193 | 20 | 3 | 59b8186d0221fba06a16157e9d148399ed801f38 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.40e-05 | 193 | 20 | 3 | 4c74a3f69b2cbdf139e7e66b44bd86869ac34dc0 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 8.40e-05 | 193 | 20 | 3 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.40e-05 | 193 | 20 | 3 | ff8ceeb3cfd1bef7239df490c19d181091750833 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.40e-05 | 193 | 20 | 3 | dc92680b4bb9fc26430c92e03adb839c8c3b3b98 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.40e-05 | 193 | 20 | 3 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 8.40e-05 | 193 | 20 | 3 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.53e-05 | 194 | 20 | 3 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.53e-05 | 194 | 20 | 3 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.53e-05 | 194 | 20 | 3 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | (5)_Fibroblast-C_(Myofibroblast)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 8.53e-05 | 194 | 20 | 3 | 29a72e565c19407bbd198cfbc2a78106fe830d05 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 8.66e-05 | 195 | 20 | 3 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 8.66e-05 | 195 | 20 | 3 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.66e-05 | 195 | 20 | 3 | 69a29d03e664b72f32d41876510c62345c3aed31 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.66e-05 | 195 | 20 | 3 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.66e-05 | 195 | 20 | 3 | 1c1135be421af98cd0077bec1ff2c4158d42aa21 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 8.66e-05 | 195 | 20 | 3 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 8.66e-05 | 195 | 20 | 3 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.66e-05 | 195 | 20 | 3 | 3a0cad69cfc150a27a0666f612f5294c817197d7 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.66e-05 | 195 | 20 | 3 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.66e-05 | 195 | 20 | 3 | 1cffae2b08dbfa1c633ce24023e89b66d28b5431 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.66e-05 | 195 | 20 | 3 | f5e91ce20a7ce528dc4c1a968c7bf096bf45c528 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.66e-05 | 195 | 20 | 3 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.66e-05 | 195 | 20 | 3 | 1f005ee1da66b539bd200aaa98f46edbbc7f12e4 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.66e-05 | 195 | 20 | 3 | 10f307aef8f4d9e71c501d5bcedb84d3be7a4d1b | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.66e-05 | 195 | 20 | 3 | 11d421bbbb71425d59cbdd673e052e00d5f0a768 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.66e-05 | 195 | 20 | 3 | c96755d2eb98112b703b5dbee9c88730ace7dcbf | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.66e-05 | 195 | 20 | 3 | 2b8ee7990267bb52b7e6ae03f509ffebf8908122 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 8.66e-05 | 195 | 20 | 3 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.66e-05 | 195 | 20 | 3 | 9cef6f18664518060af7c192310dddce6d70345a | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.66e-05 | 195 | 20 | 3 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.79e-05 | 196 | 20 | 3 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.79e-05 | 196 | 20 | 3 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.79e-05 | 196 | 20 | 3 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | LPS_IL1RA_TNF|World / Treatment groups by lineage, cell group, cell type | 8.92e-05 | 197 | 20 | 3 | 0a6550dce156fc81f15b1e7830d331ca50d87d06 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.92e-05 | 197 | 20 | 3 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.92e-05 | 197 | 20 | 3 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.92e-05 | 197 | 20 | 3 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.92e-05 | 197 | 20 | 3 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.06e-05 | 198 | 20 | 3 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.06e-05 | 198 | 20 | 3 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)|367C / Donor, Lineage, Cell class and subclass (all cells) | 9.06e-05 | 198 | 20 | 3 | a9afedbc0556faf4a46f7bf28f4a9adb3bc859d8 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 9.06e-05 | 198 | 20 | 3 | 7b5350768f306ec528e271d2ac4470bf668ec6f0 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.06e-05 | 198 | 20 | 3 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.06e-05 | 198 | 20 | 3 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | PCW_10-12-Mesenchymal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.19e-05 | 199 | 20 | 3 | a09292de4c4447b8eee55d401808e43b817321cc | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 9.19e-05 | 199 | 20 | 3 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| Drug | Vpgvg | 1.54e-05 | 7 | 20 | 2 | CID006452594 | |
| Disease | Geleophysic dysplasia | 3.51e-06 | 5 | 18 | 2 | C3489726 | |
| Disease | Acromicric Dysplasia | 3.51e-06 | 5 | 18 | 2 | C0265287 | |
| Disease | lifestyle measurement, systolic blood pressure | 1.26e-05 | 9 | 18 | 2 | EFO_0006335, EFO_0010724 | |
| Disease | myocardial infarction (is_marker_for) | 1.84e-04 | 33 | 18 | 2 | DOID:5844 (is_marker_for) | |
| Disease | optic cup area measurement | 5.31e-04 | 56 | 18 | 2 | EFO_0006940 | |
| Disease | migraine disorder, endometriosis | 9.00e-04 | 73 | 18 | 2 | EFO_0001065, MONDO_0005277 | |
| Disease | alcohol drinking | 1.11e-03 | 81 | 18 | 2 | EFO_0004329 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DKAEEQCQEHQELDC | 671 | Q5JQC9 | |
| QEEIAEEVETSICEC | 451 | Q9C0F0 | |
| LEEDSVCCVEEEEEE | 56 | Q96EL1 | |
| VCCVEEEEEEEEEAV | 61 | Q96EL1 | |
| QENECQHEAVCKDEI | 571 | Q5T1H1 | |
| EEVNIICCEKVEQDA | 36 | Q9NPP4 | |
| EEEEEEPCVICHENL | 1141 | Q86Y13 | |
| ENELALSCCQEEDED | 391 | Q9UNX9 | |
| ERECIEEICDFEEAK | 56 | P04070 | |
| DKLLVCEDIDECQNG | 1801 | P35555 | |
| LQNEKCEDIDECVEE | 2006 | P35555 | |
| EEDINECEREECENG | 4096 | Q8TDW7 | |
| LLECVDVDECLDESN | 1031 | Q9NS15 | |
| NCCKEKEAEDEENFE | 366 | Q69YH5 | |
| AELMEDECEEVEHQC | 2111 | Q9H583 | |
| DECEEVEHQCQKTIQ | 2116 | Q9H583 | |
| ELGDCNEDLEQVEKC | 646 | Q9HCB6 | |
| EQLKEDDVECIVNQD | 571 | Q8IVB4 | |
| LEILCENECTETDIE | 656 | Q8IVG5 | |
| EVDVDDCQDVASECE | 56 | P10599 | |
| SNKLEVEDEQVCCEA | 1276 | O00507 | |
| SCEEVDDCKDQLEKQ | 151 | Q9UJW8 | |
| EELDNVVCECNKKED | 206 | Q8N6V9 |